Staar Surgical Co financials
$22.43+7.47%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jul 3 | Q1 '26 Apr 3 | Q4 '25 Jan 2 | Q3 '25 Sep 26 | Q2 '25 Jun 27 | Q1 '25 Mar 28 | Q4 '24 Dec 27 | Q3 '24 Sep 27 | Q2 '24 Jun 28 | Q1 '24 Mar 29 | Q4 '23 Dec 29 | Q3 '23 Sep 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $93.5M | $93.5M | $57.8M | $94.7M | $44.3M | $42.6M | $49.0M | $88.6M | $99.0M | $77.4M | $76.3M | $80.3M |
| Gross profit | $69.7M | $68.9M | $43.7M | $77.9M | $32.8M | $28.0M | $31.6M | $68.5M | $78.4M | $61.0M | $60.7M | $63.6M |
| Gross margin | 74.5% | 73.6% | 75.7% | 82.2% | 74.0% | 65.8% | 64.7% | 77.3% | 79.2% | 78.9% | 79.6% | 79.2% |
| Operating income | $10.1M | $8.0M | -$22.8M | $18.5M | -$30.0M | -$57.4M | -$27.9M | $5.7M | $11.9M | -$2.3M | $10.4M | $6.3M |
| Net income | $8.1M | $5.2M | -$18.3M | $8.9M | -$16.8M | -$54.2M | -$34.2M | $10.0M | $7.4M | -$3.3M | $7.8M | $4.8M |
| Net margin | 8.6% | 5.6% | −31.7% | 9.4% | −37.9% | −127.3% | −69.9% | 11.3% | 7.5% | −4.3% | 10.2% | 6.0% |
| Diluted EPS | $0.16 | $0.10 | $-0.37 | $0.18 | $-0.34 | $-1.10 | $-0.71 | $0.20 | $0.15 | $-0.07 | $0.16 | $0.10 |
| EBITDA | $13.4M | $12.9M | -$19.7M | $20.5M | -$22.6M | -$32.3M | -$25.5M | $7.4M | $13.4M | -$1.0M | $11.6M | $7.6M |
| Operating cash flow | $19.7M | -$21.7M | -$3.9M | $2.7M | -$27.2M | -$5.7M | $642.0K | $3.8M | -$10.4M | $21.7M | $32.0M | -$6.0M |
| Free cash flow | $19.2M | -$22.1M | -$5.6M | $1.8M | -$29.0M | -$7.2M | -$5.1M | -$2.4M | -$16.6M | $16.5M | $28.9M | -$15.2M |
| Diluted shares | 51.5M | 50.9M | 48.9M | 50.5M | 49.5M | 49.3M | 48.1M | 49.7M | 49.8M | 48.9M | 49.3M | 49.4M |
Balance sheet
| Period end | Jul 3 | Apr 3 | Jan 2 | Sep 26 | Jun 27 | Mar 28 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $148.6M | $131.9M | $153.2M | $176.2M | $167.1M | $173.1M |
| Short-term investments | $32.9M | $32.0M | $34.4M | $16.5M | $22.8M | $49.6M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $475.2M | $451.1M | $451.7M | $456.4M | $437.8M | $457.4M |
| Total liabilities | $109.8M | $98.8M | $107.5M | $102.6M | $101.2M | $107.4M |
| Shareholders' equity | $365.4M | $352.4M | $344.2M | $353.8M | $336.6M | $350.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology